Clinical Characteristics of EMRAC study cohort
| White | Black | Hispanic | Other | Total | |
|---|---|---|---|---|---|
| N | 102 | 195 | 85 | 71 | 453 |
| Hypertension [N (%)] | 36 (35.3%) | 79 (40.5%) | 24 (28.2%) | 31 (43.7%) | 170 (37.5%) |
| Coronary Artery Disease [N (%)] | 12 (11.8%) | 14 (7.2%) | 3 (5.9%) | 2 (2.8%) | 31 (6.8%) |
| Other Heart Disease [N (%)] | 11 (10.8%) | 6 (3.1%) | 2 (2.4%) | 2 (2.8%) | 21 (4.6%) |
| Fracture [N (%)] | 11 (10.8%) | 8 (4.1%) | 2 (2.4%) | 2 (2.8%) | 23 (5.1%) |
| Psychiatric Disease [N (%)] | 5 (4.9%) | 10 (5.1%) | 1 (1.2%) | 0 (0.0%) | 16 (3.5%) |
| Diabetes [N (%)] | 11 (10.8%) | 33 (16.9%) | 9 (10.6%) | 8 (11.3%) | 61 (13.5%) |
| Cancer [N (%)] | 9 (8.8%) | 8 (4.1%) | 5 (5.9%) | 3 (4.2%) | 25 (5.5%) |
| Stomach [N (%)] | 8 (7.8%) | 9 (4.6%) | 8 (9.4%) | 7 (9.9%) | 32 (7.1%) |
| Stroke [N (%)] | 4 (3.9%) | 6 (3.1%) | 2 (2.4%) | 2 (2.8%) | 14 (3.1%) |
| Hyperlipidemia [N (%)] | 19 (18.6%) | 29 (14.9%) | 9 (10.6%) | 12 (16.9%) | 69 (15.2%) |
| Chronic Bronchitis [N (%)] | 10 (9.8%) | 17 (8.7%) | 5 (5.9%) | 5 (7.0%) | 37 (8.2%) |
| Pulmonary Fibrosis [N (%)] | 2 (2.0%) | 5 (2.6%) | 4 (4.7%) | 0 (0.0%) | 11 (2.4%) |
| Kidney Disease [N (%)] | 3 (2.9%) | 5 (2.6%) | 0 (0.0%) | 2 (2.8%) | 10 (2.2%) |
| RAPID3 | 13.1 (6.8) | 12.5 (7.4) | 14.8 (6.9) | 13.7 (7.2) | 13.3 (7.1) |
| Enrollment | |||||
| RDCI | 1.8 (2.1) | 1.7 (2.0) | 1.2 (1.7) | 1.6 (1.8) | 1.6 (1.9) |
| COUNT | 1.0 (1.3) | 1.0 (1.3) | 0.7 (0.9) | 0.9 (1.1) | 0.9 (1.2) |
Mean (SD) reported unless otherwise noted.